With a 54% ratio of institutional ownership, having increased with more and larger stakes, we are in good company. If these analysts who gave outperform ratings and the 'tutes are wrong, (doubtful) then we lose some money, but risk/reward with all I've read on the trials going well, is sure strongly in our favor for a home run in the multiples of our money.
I think it's just as likely that firms forcing the continuation of a downtrend on a good stock like SNTA can be a stronger force than the influence of what gets out ahead of time from (conferences like) ASCO. Now, should a good blogger or analyst write a credible article that could hit the next day, like Monday June 1st, that can abruptly break a trend and spike the stock price. Ganetespib is not an easily understood drug in trials. Ganetespib trial results I've read are written by PhD's for other PhD's and the medical community, or scientists. Retail investors may need results interpreted before they act, but institutions have already taken their positions, which with SNTA, currently represents 54.5% of shares, or 73,200,337 of 134,000,000 total shares. Let's look for a good article next week, it would be timely and much appreciated. In it to win it.
Good to be here, I'm JR from Kirkland, WA. I started small here with 1,000 shares when it was $6.50. Added on the way down, then stopped. Waited with red ink, then as my conviction grew started adding low $2s, then more on the way up. Traded once but watched it run away from me, then it yo-yo'd and came right back down. Added more, now holding 60,000 shares averaged at 3.26. Hope to see $50 a share by 2018. I have this year stepped into supporting myself from my investments and love the freedom and the returns. I am outperforming by investing exclusively in biotech and healthcare. I was fortunate to have picked Horizon Pharma at 2.13 a share in 2013. It's now 32.50. Hope to do the same here. I have investments now in 10 companies.
Hi Steve, that's my brother's name. He watches what I do, but so far has only watched me kill it. He's so conservative, I'm a risk taker. You fly jets, you're a risk taker, you should post more Steve!
(Reuters) - A U.S. House of Representatives committee on Thursday unanimously approved a bill to speed new drugs to the market, overcoming last-minute wrangling over how to pay for the legislation.
The bill, known as the 21st Century Cures Act, requires the Food and Drug Administration to incorporate patient experience into its decision-making, streamline its review of drugs for additional uses, and consider more flexible forms of clinical trials.
The bill, developed by the House Energy and Commerce Committee was spearheaded by Republican Congressman Fred Upton and Democrat Diana DeGette. Upton's goal is for the bill to be voted on by the full House in June. A parallel measure is being developed in the Senate.
Patient advocacy groups cheered the bill. Ellen Sigal, chair of the Friends of Cancer Research, said it "creates a more cohesive, efficient, effective and patient-centered research and regulatory system."
Some critics fear aspects of the bill will weaken the FDA's ability to restrict marketing of drugs for unapproved uses and potentially lower safety and efficacy standards by relying on less rigorous clinical data.
The bill would increase funding to the National Institutes of Health by $10 billion over five years. It would also boost FDA funding by $550 million over the same period. An official cost of the legislation is expected to be released within the next few weeks.
After last-minute negotiations lawmakers agreed to pay for the legislation using a variety of offsets including the sale of eight million barrels of oil for eight years from the Strategic Petroleum Reserve, bringing in around $5.2 billion.
Offsets would also include certain changes in government payments to insurance companies, and a reduction in Medicaid payments for some medical equipment.
The bill would exempt FDA user fee programs.
Hi Steve in San Diego, hope you do well here, my brother Steve has way more money than I do, but that will change as my IDRA ship comes in, he should own some like we do, but he doesn't invest in stocks, too bad!
Steve, we're in SNTA together, I am relative newcomer, my shares are at 2.24. You been there long? That one is being punished for no reason other than no news. We know that can change in a hurry, I am still buying it.
I was going to ask who is Dan Erdman and then you posted as him? Are you the one who he is suggesting will replace Lief on the board? I am sorry, but this post is lost on me, since I don't know about you, or the other guy if it's not you. Why would this be good if so?
Saw this post on the ARNA board today...
norton_1223 • 16 hours ago
users liked this posts
users disliked this posts
Time to load up big on MSTX
ARNA's CEO resigned from their board citing "conflict of interest". Translation: AIR001 is going well. ROTH has a $3 target.
Sentiment: Strong Buy
Nice! Not even worried a little, Vince will put out something worthwhile for shareholders.
Exactly, if there ever was a poster who is negative and should stop posting , it's ruswise. We were up .04 today, granted, not much, but the reversal was noted and could be the beginning of a trend change. I've noticed a lot of stocks get to the low $2's and reverse, we have every good reason for people to accumulate and one press release later, the stock breaks out.
You were right, it opened higher then spent the rest of the session treading water before it dropped.
We agree, insiders know what's coming, they've only held or added shares. Kovner should write an article about judging the risk of a portfolio that is mostly one stock. I'd sure like to know what he knows about SNTA, and what else he invests in.
We had what may be a trend reversal day today in SNTA, it outperformed NBS, which was opposite of what I was expecting. IBB was down and pulled a lot of my stocks down today. Like both, bought both starting in May.
There are so many good reasons to jump all over this stock at these prices. I am so convinced of the direction of this stock, after our reversal of yesterday with follow through of today, that I went into the stock after hours and bought another 2,000 shares, now holding 15,000 at 2.24. Yes, I had to pay 2.24 for those new shares, but this didn't increase my basis and now I am poised with a full position when it breaks out any day now. Good luck to long holders, it's our time!
Sentiment: Strong Buy
I see a lot of posting activity here by you today, are you new to the stock? Sure like your enthusiasm, as compared to ruswise's negative posting!
Stockcharts is a good resource, the best in my opinion. I have had a subscription there for four years and it has become an indispensable tool in my investing practice. Their rates are cheap, a small day trade profit pays for your year and then you have the opportunity to archive all your charts of any company you ever invested in, or want to follow. Their chartschool is amazing, and every year they have several conferences, the one called Chartcon is held in Seattle every summer. The company is a Redmond, WA company, so they hold it in Seattle. I love their management, and they bring in guest speakers that literally are the Who's Who of great books on technical trading. Can you tell I am a big fan?
Sentiment: Strong Buy
Oz and Minne, if you were both here that day the stock zoomed up to $27, were you taking profits and selling into the demand? It's so hard to know whether to hold 'em or fold them, particularly if you have such a deep respect for the Company, because we know it is worth the price paid!
Sentiment: Strong Buy